디지털 당뇨병 관리 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The global digital diabetes management market size is expected to reach USD 101.62 Billion in 2034 from USD 31.18 Billion in 2025, growing at a CAGR of 14.03% during 2026-2034.The global digital diabetes management market has expanded rapidly with the growth of digital health technologies. Rising diabetes cases worldwide have increased the need for continuous monitoring and management tools. Mobile apps, wearable devices, and connected glucose monitors have improved patient engagement and treatment outcomes.

Major drivers include the increasing use of smartphones and wearable health devices. Telemedicine services and remote patient monitoring systems have gained popularity, especially after the pandemic. Growing awareness about self-care and preventive healthcare supports market growth. Healthcare providers are also adopting digital platforms to track patient data more effectively.

Looking ahead, the market is expected to grow strongly with advancements in artificial intelligence and data analytics. Integration of digital tools with healthcare systems will improve personalized treatment plans. However, data privacy concerns and high device costs may limit adoption in some regions. Overall, digital transformation in healthcare will support long-term growth.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Product & Service

• Devices (Smart Glucose Meters, Continuous Glucose Monitoring (Cgm) Systems, Smart Insulin Pens, Smart Insulin Pumps/Closed-Loop Pumps & Smart Insulin Patches)
• Application (Diabetes & Blood Glucose Tracking Apps, Obesity & Diet Management Apps)
• Data Management Software & Platforms
• Services

By Device Type

• Handheld Devices
• Wearable Devices

By End User

• Self/Home Healthcare
• Hospitals & Specialty Diabetes Clinics
• Academic & Research Institutes

COMPANIES PROFILED

• Abbott, Dexcom, Medtronic, Insulet, Roche, Novo Nordisk, Tandem Diabetes Care, Omada Health, DarioHealth, Ascensia Diabetes Care, mySugr/Roche, Senseonics, embecta, EOFlow, Sequel Med Tech, Beta Bionics, Bigfoot Biomedical, AgaMatrix, Livongo/Teladoc, Glooko

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL DIGITAL DIABETES MANAGEMENT MARKET: BY PRODUCT & SERVICE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product & Service
• 4.2. Devices (Smart Glucose Meters, Continuous Glucose Monitoring (Cgm) Systems, Smart Insulin Pens, Smart Insulin Pumps/Closed-Loop Pumps & Smart Insulin Patches) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Application (Diabetes & Blood Glucose Tracking Apps, Obesity & Diet Management Apps) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Data Management Software & Platforms Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL DIGITAL DIABETES MANAGEMENT MARKET: BY DEVICE TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Device Type
• 5.2. Handheld Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Wearable Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL DIGITAL DIABETES MANAGEMENT MARKET: BY END USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End User
• 6.2. Self/Home Healthcare Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Hospitals & Specialty Diabetes Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Academic & Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL DIGITAL DIABETES MANAGEMENT MARKET: BY REGION 2022-2034 (USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product & Service
  • 7.2.2 By Device Type
  • 7.2.3 By End User
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product & Service
  • 7.3.2 By Device Type
  • 7.3.3 By End User
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Spain
  • 7.3.9 Russia
  • 7.3.10 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product & Service
  • 7.4.2 By Device Type
  • 7.4.3 By End User
  • 7.4.4 China
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 India
  • 7.4.8 Australia
  • 7.4.9 South East Asia
  • 7.4.10 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product & Service
  • 7.5.2 By Device Type
  • 7.5.3 By End User
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product & Service
  • 7.6.2 By Device Type
  • 7.6.3 By End User
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL DIGITAL DIABETES MANAGEMENT INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Abbott
  • 9.2.2 Dexcom
  • 9.2.3 Medtronic
  • 9.2.4 Insulet
  • 9.2.5 Roche
  • 9.2.6 Novo Nordisk
  • 9.2.7 Tandem Diabetes Care
  • 9.2.8 Omada Health
  • 9.2.9 DarioHealth
  • 9.2.10 Ascensia Diabetes Care
  • 9.2.11 MySugr/Roche
  • 9.2.12 Senseonics
  • 9.2.13 Embecta
  • 9.2.14 EOFlow
  • 9.2.15 Sequel Med Tech
  • 9.2.16 Beta Bionics
  • 9.2.17 Bigfoot Biomedical
  • 9.2.18 AgaMatrix
  • 9.2.19 Livongo/Teladoc
  • 9.2.20 Glooko